NYSE · ALC
Healthcare · Medical - Instruments & Supplies
$67.76
Up+$0.02 (+0.03%)
Updated Sep 16, 2026, 8:06 AM
SID Score
5.5/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
ALC closed at $67.76 after 20 trading sessions, down 7.87% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $67.06 | $67.935 | $66.95 | $67.76 | 1.51M |
| Sep 14, 2026 | $67.31 | $67.79 | $66.64 | $67.74 | 1.87M |
| Sep 11, 2026 | $67.26 | $67.415 | $65.94 | $66.03 | 1.94M |
| Sep 10, 2026 | $67.42 | $67.70 | $66.53 | $66.55 | 1.57M |
| Sep 9, 2026 | $68.90 | $69.37 | $68.255 | $68.43 | 1.96M |
| Sep 8, 2026 | $69.64 | $69.64 | $68.855 | $69.12 | 1.66M |
| Sep 4, 2026 | $70.89 | $71.14 | $70.48 | $70.50 | 1.34M |
| Sep 3, 2026 | $72.82 | $73.22 | $71.195 | $72.08 | 950.48K |
| Sep 2, 2026 | $71.72 | $73.52 | $71.72 | $72.24 | 1.33M |
| Sep 1, 2026 | $72.56 | $72.59 | $71.38 | $71.75 | 1.4M |
| Aug 31, 2026 | $71.89 | $72.45 | $71.39 | $72.06 | 1.11M |
| Aug 28, 2026 | $71.69 | $72.07 | $71.38 | $72.01 | 1.18M |
| Aug 27, 2026 | $72.46 | $72.82 | $72.16 | $72.23 | 716.52K |
| Aug 26, 2026 | $72.85 | $73.11 | $72.585 | $72.67 | 772.16K |
| Aug 25, 2026 | $73.35 | $73.4299 | $72.695 | $73.37 | 816.27K |
| Aug 24, 2026 | $73.34 | $73.91 | $73.21 | $73.70 | 1.16M |
| Aug 21, 2026 | $72.80 | $73.84 | $72.64 | $73.63 | 994.23K |
| Aug 20, 2026 | $74.46 | $74.68 | $72.87 | $72.93 | 1.5M |
| Aug 19, 2026 | $73.67 | $74.825 | $73.43 | $74.26 | 1.65M |
| Aug 18, 2026 | $73.60 | $74.40 | $73.50 | $73.55 | 1.56M |
The latest Smart Investors Daily articles mentioning ALC.
ALC research
Company profile and research snapshot.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 13, 2026 | BERENBERG | Buy | — |
| Jul 12, 2026 | DAY BY DAY | Sell | — |
| Jul 9, 2026 | EQUITA SIM | Buy | — |
| Jun 24, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Jun 4, 2026 | NEEDHAM & COMPANY INC. | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 8, 2026
UBS has recruited a trio of financial advisor teams managing around $2.65 billion in client assets. The teams joined UBS on Friday, according to registration records. The Mason Cisney Alcon Wealth Management Group, based in Pueblo, Colo., managed $1.4 billion at Morgan Stanley and produced annual revenue of more than $3.5 million.
Yahoo · Sep 4, 2026
Alcon's acquisitions, partnerships and new product launches support growth, but tariffs and intense competition remain key risks.
Yahoo · Sep 3, 2026
GENEVA, September 03, 2026--Alcon Launches UNITY® M, a Premium Ophthalmic Microscope Delivering Precise Control
Yahoo · Sep 3, 2026
Investors need to pay close attention to ALC stock based on the movements in the options market lately.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ALC.
